1/33
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
desmoplasia
fibrotic state showcased by tumours
inc deposition, altered organisation, post translational modification of ECM proteins
receptors which bind to collagen
DDR1/DDR2 - discoidin domain receptors
what do integrins bind to
collagen, fibronectin and laminin
what are syndecans
family of heparan sulfate proteoglycans
interact with fibronectin
what is the laminin receptor
67kDa receptor
What are the major signaling components for interacting with the intracellular signals and hallmarks of cancer?
VEGF, FAK, Rho/ROCK, ERK/P13K
How does the G1/S cell cycle in proliferation link to the ECM?
adhesion to the ECM
allows growth factor dependent activation of Ras
stimulates Erk signalling
What happens in the absence of integrin mediated adhesion to the ECM?
Src and Erk signalling is not activated
tumour supressor inhibitors remain high
prevents cell proliferation
role of focal adhesion in ECM signalling
mediates signals to tumour cells
promotes activation of P13K pathway
inc glycolysis
stiffened tumours have upregulation of this pathway
what are the 2 matrisome proteins
core matrisome
matrisome associated
core matrisome proteins
structural components
collagen - triple helical structures
proteoglycans - long GAGs, provide lubrication by binding to water
glycoproteins - shorter, more complex oligosaccharide side chains, ECM assembly, binding growth factors
matrisome associated proteins
secreted proteins that associate or modify the ECM
mass spectrometry proteomics
tissue undergoes mechanical or chemical disruption (surfactant)
protein is extracted
trypsin digests to give complex peptide sequences
liquid chromatography coupled tandem mass spectrometry
1st MS quantifies signal, 2nd breaks down the peptide for identification
matrisome project database for composition of protein identification
does ECM secretion have circadian rhythmicity
yes
can the matrisome be altered by disease
yes
what increases the stiffness of the ECM
inc conc of matrix proteins
higher polymerisation
what features of the matric define the mechanical properties
identification of proteins
concentration of matrix proteins
organisation of matrix proteins
crosslinking of matrix proteins
mineral deposition
hallmarks of cancer
most cancers acquire the same functional capabilities
sustaining proliferative signalling
evading growth suppressors
avoiding immune destruction
enabling replicative immortality
tumour promoting inflammation
activation invasion and metastasis
inducing angiogenesis
genome instability and mutation
resisting cell death
deregulating cellular energetics
which cell behaviours can be influenced by mechanical signals
cell morphology
contractility
propagation rate and apoptosis
cell movement
differentiation
which cancer hallmarks are influenced by matrix and matrix mechanics
sustaining proliferative signalling
resisting cell death
activating invasion and metastasis
focal adhesion kinase FAK
limits sensitivity to growth inhibitors and apoptosis
MAPK/ERK
promotes cell proliferation
VEGF
induces angiogenesis (formation of blood vessels)
Rho/ROCK and Rac
drives invasion and metastasis (described in cell contractility lectures)
what is the most significant risk factor for breast cancer after ageing
high mammographic density
what is associated with high mammographic density
increased fibrillar collagen
higher fibre organisation
much stiffer
cancer matrix composition
misregulated cell proliferation
inc matrix production by fibroblasts
inc crosslinking by LOX
reorganisation by proteases
inc stiffness
limiting factors in metastasis
invasion into surrounding tissue is limited by cells ability to degrade the matrix
what is the stiffest organelle
nucleus
determined by the lamin proteins in the envelope
lamin A and lamin B
lamin a expression and migration
overexpression of lamin A will impede migration
knowckdown will make tumours grow more rapidly
cells which have least lamin A can spread into surrounding tissue, more easily deformed
transglutaminase TGM
crosslinking protein
links peptide P1 and P2
LOX proteins in cancer
elevated in many cancers
tumour hypoxia drives inc secretion of LOX
MMP matrix metalloproteinase
range of ECM substrates
zinc dependent
regulated by TIMPs
excessive activity found in tumour cells and metastasis
ADAMTS function
collagen processing
proteoglycan cleavage